Bioactivation of carbamate-based 20(S)-camptothecin prodrugs

Neta Pessah, Mika Reznik, Marina Shamis, Ferda Yantiri, Hong Xin, Katherine Bowdish, Noam Shomron, Gil Ast, Doron Shabat

Research output: Contribution to journalArticlepeer-review

Abstract

Two new prodrugs of CPT were synthesized, based on carbamate linkages between the 20-hydroxy group of CPT and a linker designed to be enzymatically removed by either Penicillin-G-Amidase or catalytic antibody 38C2. Cell growth inhibition assays showed an up-to-2250-fold difference in toxicity between the prodrugs and the active drug. A significant increase in toxicity was observed upon incubation of the enzyme or the catalytic antibody with the corresponding prodrug The described derivatives of CPT further our knowledge in the design of prodrugs for use in selective approaches for targeted chemotherapy.

Original languageEnglish
Pages (from-to)1859-1866
Number of pages8
JournalBioorganic and Medicinal Chemistry
Volume12
Issue number8
DOIs
StatePublished - 15 Apr 2004

Keywords

  • ADEPT
  • Enzymes
  • Prodrug Activation
  • Selective Chemotherapy

Fingerprint

Dive into the research topics of 'Bioactivation of carbamate-based 20(S)-camptothecin prodrugs'. Together they form a unique fingerprint.

Cite this